{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:13:58Z","timestamp":1740172438646,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s42000-022-00414-6","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T03:02:26Z","timestamp":1667876546000},"page":"139-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An acromegaly case treated with clomiphene citrate: add-on treatment in primary medical therapy"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3616-8051","authenticated-orcid":false,"given":"Esma Pehlivan","family":"Koroglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0229-3452","authenticated-orcid":false,"given":"Utku Erdem","family":"Soyaltin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-5600","authenticated-orcid":false,"given":"Sena","family":"Yeral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-2655","authenticated-orcid":false,"given":"Banu Sarer","family":"Yurekli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"issue":"2","key":"414_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1365-2265.2001.01214.x","volume":"54","author":"L Katznelson","year":"2001","unstructured":"Katznelson L, Kleinberg D, Vance ML, Stavrou S, Pulaski KJ, Schoenfeld DA, Hayden DL, Wright ME, Woodburn CJ, Klibanski A (2001) Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin Endocrinol 54(2):183\u2013188. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01214.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"414_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667\u2013678. https:\/\/doi.org\/10.1007\/s11154-020-09588-z","journal-title":"Rev Endocr Metab Disord"},{"issue":"Suppl 2","key":"414_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000087752","volume":"64","author":"JO J\u00f8rgensen","year":"2005","unstructured":"J\u00f8rgensen JO, Christensen JJ, Vestergaard E, Fisker S, Ovesen P, Christiansen JS (2005) Sex steroids and the growth hormone\/insulin-like growth factor-I axis in adults. Horm Res 64(Suppl 2):37\u201340. https:\/\/doi.org\/10.1159\/000087752","journal-title":"Horm Res"},{"issue":"5","key":"414_CR4","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1210\/jc.2014-3913","volume":"100","author":"FH Duarte","year":"2015","unstructured":"Duarte FH, Jallad RS, Bronstein MD (2015) Clomiphene citrate for treatment of acromegaly not controlled by conventional therapies. J Clin Endocrinol Metab 100(5):1863\u20131869. https:\/\/doi.org\/10.1210\/jc.2014-3913","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"414_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/0002-9343(80)90470-2","volume":"69","author":"DR Clemmons","year":"1980","unstructured":"Clemmons DR, Underwood LE, Ridgway EC, Kliman B, Kjellberg RN, Van Wyk JJ (1980) Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status. Am J Med 69(4):571\u2013575. https:\/\/doi.org\/10.1016\/0002-9343(80)90470-2","journal-title":"Am J Med"},{"issue":"1\u20132","key":"414_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0303-7207(94)90072-8","volume":"103","author":"HM Domen\u00e9","year":"1994","unstructured":"Domen\u00e9 HM, Mar\u00edn G, Sztein J, Yu YM, Baron J, Cassorla FG (1994) Estradiol inhibits growth hormone receptor gene expression in rabbit liver. Mol Cell Endocrinol 103(1\u20132):81\u201387. https:\/\/doi.org\/10.1016\/0303-7207(94)90072-8","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"414_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/er.2003-0035","volume":"25","author":"KC Leung","year":"2004","unstructured":"Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25(5):693\u2013721. https:\/\/doi.org\/10.1210\/er.2003-0035","journal-title":"Endocr Rev"},{"issue":"3","key":"414_CR8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1073\/pnas.0337600100","volume":"100","author":"KC Leung","year":"2003","unstructured":"Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ, Ho KK (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100(3):1016\u20131021. https:\/\/doi.org\/10.1073\/pnas.0337600100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"414_CR9","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1210\/endo.139.4.5931","volume":"139","author":"L Fern\u00e1ndez","year":"1998","unstructured":"Fern\u00e1ndez L, Flores-Morales A, Lahuna O, Sliva D, Norstedt G, Haldos\u00e9n LA, Mode A, Gustafsson JA (1998) Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)\/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Endocrinology 139(4):1815\u20131824. https:\/\/doi.org\/10.1210\/endo.139.4.5931","journal-title":"Endocrinology"},{"issue":"8","key":"414_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/BF03348000","volume":"20","author":"R Cozzi","year":"1997","unstructured":"Cozzi R, Attanasio R, Oppizzi G, Orlandi P, Giustina A, Lodrini S, Da Re N, Dallabonzana D (1997) Effects of tamoxifen on GH and IGF-I levels in acromegaly. J Endocrinol Invest 20(8):445\u2013451. https:\/\/doi.org\/10.1007\/BF03348000","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"414_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1530\/eje.0.1500481","volume":"150","author":"EV Dimaraki","year":"2004","unstructured":"Dimaraki EV, Symons KV, Barkan AL (2004) Raloxifene decreases serum IGF-I in male patients with active acromegaly. Eur J Endocrinol 150(4):481\u2013487. https:\/\/doi.org\/10.1530\/eje.0.1500481","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"414_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1530\/eje.0.1480443","volume":"148","author":"R Attanasio","year":"2003","unstructured":"Attanasio R, Barausse M, Cozzi R (2003) Raloxifene lowers IGF-I levels in acromegalic women. Eur J Endocrinol 148(4):443\u2013448. https:\/\/doi.org\/10.1530\/eje.0.1480443","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"414_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/s0015-0282(16)57597-9","volume":"63","author":"TL B\u00fctzow","year":"1995","unstructured":"B\u00fctzow TL, Kettel LM, Yen SS (1995) Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome. Fertil Steril 63(6):1200\u20131203. https:\/\/doi.org\/10.1016\/s0015-0282(16)57597-9","journal-title":"Fertil Steril"},{"issue":"11","key":"414_CR14","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1093\/humrep\/15.11.2302","volume":"15","author":"V de Leo","year":"2000","unstructured":"de Leo V, la Marca A, Morgante G, Ciotta L, Mencaglia L, Cianci A, Petraglia F (2000) Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome. Hum Reprod 15(11):2302\u20132305. https:\/\/doi.org\/10.1093\/humrep\/15.11.2302","journal-title":"Hum Reprod"},{"key":"414_CR15","doi-asserted-by":"publisher","first-page":"7925019","DOI":"10.1155\/2018\/7925019","volume":"2018","author":"JD Palacios","year":"2018","unstructured":"Palacios JD, Komotar RJ, Kargi AY (2018) Successful treatment of acromegaly and associated hypogonadism with first-line clomiphene therapy. Case Rep Endocrinol 2018:7925019. https:\/\/doi.org\/10.1155\/2018\/7925019","journal-title":"Case Rep Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-022-00414-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T03:33:10Z","timestamp":1678764790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-022-00414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["414"],"URL":"https:\/\/doi.org\/10.1007\/s42000-022-00414-6","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors confirm that the patients provided their consent for the publication of their medical and personal information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}